Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
4
×
wisconsin top stories
biogen
gene therapy
novartis
vc
cancer
celgene
clinical trials
democrats
immunomedics
ipo
medicare
migraine
What
bio
ipo
4
×
roundup
4
×
biogen
new
week
activity
allogene
america
approvals
arena’s
bounty
cancer
cig
clamped
comeback
companies
continues
convoluted
corner
covid
crispr
deals
delays
delivered
democrats
developing
diversity
dreams
economic
expressing
fast
fda
head
headaches
healthcare
holding
hot
immunotherapy
including
Language
unset
Current search:
ipo
×
roundup
×
" wisconsin blog main "
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More